Morning Market Movers (GENE, PTX, CIMT, GENT)

Genetic Technologies Ltd GENE shares surged 26.19% to $4.24 at 10:00 am. GENE had $3.28 million in total cash and $379.71 thousand in total debt for the recent quarter. Pernix Therapeutics Holdings Inc PTX jumped 24.70% to $9.85. PTX reported that the US Food and Drug Administration (FDA) has approved Natroba for treatment of head lice. Cimatron, Limited CIMT climbed 18.18% to $4.29. CIMT reported that CimatronE will partner with Haas Automation at IMTEX India. Gentium SpA GENT shares advanced 16.50% to $9.18. GENT's trailing-twelve-month ROE is 35.72%. Read more from Benzinga's Markets.